. 2017 Dec 8;18:100. doi: 10.1186/s12875-017-0670-9

Table 7.

Association between GPs' awareness of depressive symptomatology, depression treatment and HRQOL

	Model 1		Model 2		Model 3
Variable	F	P-Value	F	P-Value	F	P-Value
Corrected model	8.968	<0.001	9.107	<0.001	7.602	<0.001
Constant	96.808	<0.001	98.089	<0.001	97.612	<0.001
GPs' awareness of depressive symptomatology	0.122	0.727			0.436	0.510
Utilisation of prescription antidepressants or psychotherapy			1.303	0.254	1.519	0.218
GPs' awareness of depressive symptomatology* Utilisation of prescription antidepressants or psychotherapy					0.087	0.768
Age	4.021	0.045	3.394	0.066	3.512	0.062
Sex (female)	1.440	0.231	1.747	0.187	1.597	0.207
Education	3.052	0.048	3.057	0.048	3.077	0.047
NYHA Class	10.399	<0.001	10.327	<0.001	9.942	<0.001
Comorbidity score	0.447	0.504	0.285	0.594	0.273	0.601
PHQ-9 Score	33.030	<0.001	35.974	<0.001	34.418	<0.001
	N = 503; R² = 0.154		N = 503; R² = 0.156		N = 503; R² = 0.157

Univariate ANCOVA with endpoint HRQOL (EQ-5D VAS) in patients screened positive for depressive symptomatology P(+). Regarding utilisation of prescription antidepressants or psychotherapy, cases with utilisation were compared with all other cases (no utilisation and cases with no available information, respectively)